Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2017 | 2018 | ||||||||
|
3-hydroxyacyl-CoA dehydratase 1 | 0.539 | 0.846 | 1.3E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
7-dehydrocholesterol reductase | 0.500 | 0.846 | 3.9E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
abhydrolase domain containing 5 | 0.641 | 0.538 | 6.4E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
acetoacetyl-CoA synthetase | 0.751 | 0.308 | 9.1E-17 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
acetyl-CoA acetyltransferase 1 | 0.538 | 0.692 | 9.9E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
acetyl-CoA carboxylase alpha | 0.480 | 0.846 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2005 | 2020 | ||||||||
|
acetyl-CoA carboxylase beta | 0.644 | 0.654 | 7.6E-47 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2018 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
actin related protein 5 | 0.931 | 0.077 | 1.1E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
activating transcription factor 2 | 0.551 | 0.808 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
activator of HSP90 ATPase activity 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
acyl-CoA oxidase 1 | 0.610 | 0.731 | 6.2E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 | ||||||||
|
acyl-CoA synthetase long chain family member 1 | 0.617 | 0.577 | 1.5E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
acyl-CoA synthetase long chain family member 4 | 0.561 | 0.769 | 0.98 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2018 | ||||||||
|
acyl-CoA thioesterase 13 | 0.729 | 0.423 | 3.1E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 9 | 0.633 | 0.692 | 1.0E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 | 0.626 | 0.500 | 0.80 |
|
disease | 0.010 | None | 1.000 | 1 | 2 | 2013 | 2013 | ||||||||
|
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2 | 0.700 | 0.423 | 1.2E-18 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 |